Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| LB Pharmaceuticals Inc | LBRX | $49.34 | $1.59B | — | |
| Innoviva, Inc. | INVA | $21.33 | $1.54B | 5.0 | — |
| Bicara Therapeutics Inc. | BCAX | $23.17 | $1.53B | — | |
| Latigo Biotherapeutics, Inc. | LTGO | $23.04 | $1.53B | — | |
| ArriVent BioPharma, Inc. | AVBP | $30.95 | $1.53B | — | |
| Absci Corporation | ABSI | $8.82 | $1.51B | — | |
| Ultragenyx Pharmaceutical Inc. | RARE | $15.30 | $1.51B | — | |
| Aktis Oncology, Inc. | AKTS | $27.05 | $1.50B | — | |
| Vor Biopharma Inc. | VOR | $25.05 | $1.48B | 0.1 | — |
| Mind Medicine (MindMed) Inc. | MNMD | $18.09 Mar 17, 2026 | $1.46B | — | |
| Maze Therapeutics, Inc. | MAZE | $26.21 | $1.46B | — | |
| Immatics N.V. | IMTX | $9.56 | $1.46B | — | |
| First Tracks Biotherapeutics, Inc. | TRAX | $40.46 | $1.45B | — | |
| Alumis Inc. | ALMS | $11.10 | $1.44B | — | |
| KalVista Pharmaceuticals, Inc. | KALV | $27.00 Jun 12, 2026 | $1.43B | — | |
| Replimune Group, Inc. | REPL | $15.04 | $1.42B | — | |
| Alto Neuroscience, Inc. | ANRO | $35.55 | $1.40B | — | |
| Alpha Tau Medical Ltd. | DRTS | $15.03 | $1.39B | — | |
| Odyssey Therapeutics, Inc. | ODTX | $28.76 | $1.38B | — | |
| Omeros Corporation | OMER | $18.95 | $1.37B | 11.5 | — |
| Cullinan Therapeutics, Inc. | CGEM | $22.09 | $1.36B | — | |
| MeiraGTx Holdings plc | MGTX | $13.89 | $1.33B | 16.0 | — |
| ORIC Pharmaceuticals, Inc. | ORIC | $12.86 | $1.33B | — | |
| Seaport Therapeutics, Inc. | SPTX | $24.86 | $1.33B | — | |
| MannKind Corporation | MNKD | $4.06 | $1.31B | — | |
| MoonLake Immunotherapeutics | MLTX | $15.01 | $1.28B | — | |
| Jade Biosciences, Inc. | JBIO | $19.90 | $1.27B | — | |
| Janux Therapeutics, Inc. | JANX | $20.24 | $1.24B | — | |
| Corvus Pharmaceuticals, Inc. | CRVS | $14.39 | $1.21B | — | |
| Monte Rosa Therapeutics, Inc. | GLUE | $13.84 | $1.18B | — | |
| Kura Oncology, Inc. | KURA | $13.25 | $1.18B | — | |
| Attovia Therapeutics, Inc. | ATTO | $25.55 | $1.17B | — | |
| Sana Biotechnology, Inc. | SANA | $3.85 | $1.15B | — | |
| Apnimed, Inc. | APMD | $27.45 | $1.14B | 11.4 | — |
| Inventiva S.A. | IVA | $4.78 | $1.13B | — | |
| Savara Inc. | SVRA | $5.37 | $1.10B | — | |
| Solid Biosciences Inc. | SLDB | $10.25 | $1.10B | — | |
| CureVac N.V. | CVAC | $4.66 Jan 6, 2026 | $1.05B | 7.0 | — |
| Obsidian Therapeutics, Inc. | OBX | $16.82 | $1.04B | — | |
| Faeth Therapeutics, Inc. | FTH | $40.05 | $1.03B | — | |
| Avalo Therapeutics, Inc. | AVTX | $19.23 | $1.03B | — | |
| Arbutus Biopharma Corporation | ABUS | $5.15 | $1.02B | 6.5 | — |
| Geron Corporation | GERN | $1.57 | $1.01B | — | |
| Ventyx Biosciences Inc | VTYX | $14.00 Mar 6, 2026 | $1.00B | — | |
| Lexicon Pharmaceuticals, Inc. | LXRX | $2.24 | $996.70M | — | |
| Immix Biopharma, Inc. | IMMX | $13.91 | $990.25M | — | |
| Candel Therapeutics, Inc. | CADL | $12.78 | $977.91M | — | |
| Ardelyx, Inc. | ARDX | $3.78 | $975.95M | — | |
| SpyGlass Pharma, Inc. | SGP | $28.94 | $967.98M | — | |
| Adlai Nortye Group Ltd. | ANL | $15.01 | $966.61M | — |
LB Pharmaceuticals Inc
Healthcare / Biotechnology
- Market Cap
- $1.59B
- P/E
- unprofitable
Innoviva, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.54B
- P/E
- 5.0
Bicara Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $1.53B
- P/E
- unprofitable
Latigo Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.53B
- P/E
- unprofitable
ArriVent BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.53B
- P/E
- unprofitable
Absci Corporation
Healthcare / Biotechnology
- Market Cap
- $1.51B
- P/E
- unprofitable
Ultragenyx Pharmaceutical Inc.
Healthcare / Biotechnology
- Market Cap
- $1.51B
- P/E
- unprofitable
Aktis Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.50B
- P/E
- unprofitable
Vor Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $1.48B
- P/E
- 0.1
Mind Medicine (MindMed) Inc.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
Maze Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
Immatics N.V.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
First Tracks Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.45B
- P/E
- unprofitable
Alumis Inc.
Healthcare / Biotechnology
- Market Cap
- $1.44B
- P/E
- unprofitable
KalVista Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.43B
- P/E
- unprofitable
Replimune Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.42B
- P/E
- unprofitable
Alto Neuroscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.40B
- P/E
- unprofitable
Alpha Tau Medical Ltd.
Healthcare / Biotechnology
- Market Cap
- $1.39B
- P/E
- unprofitable
Odyssey Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.38B
- P/E
- unprofitable
Omeros Corporation
Healthcare / Biotechnology
- Market Cap
- $1.37B
- P/E
- 11.5
Cullinan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.36B
- P/E
- unprofitable
MeiraGTx Holdings plc
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- 16.0
ORIC Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- unprofitable
Seaport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- unprofitable
MannKind Corporation
Healthcare / Biotechnology
- Market Cap
- $1.31B
- P/E
- unprofitable
MoonLake Immunotherapeutics
Healthcare / Biotechnology
- Market Cap
- $1.28B
- P/E
- unprofitable
Jade Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.27B
- P/E
- unprofitable
Janux Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.24B
- P/E
- unprofitable
Corvus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.21B
- P/E
- unprofitable
Monte Rosa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.18B
- P/E
- unprofitable
Kura Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.18B
- P/E
- unprofitable
Attovia Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.17B
- P/E
- unprofitable
Sana Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.15B
- P/E
- unprofitable
Apnimed, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.14B
- P/E
- 11.4
Inventiva S.A.
Healthcare / Biotechnology
- Market Cap
- $1.13B
- P/E
- unprofitable
Savara Inc.
Healthcare / Biotechnology
- Market Cap
- $1.10B
- P/E
- unprofitable
Solid Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $1.10B
- P/E
- unprofitable
CureVac N.V.
Healthcare / Biotechnology
- Market Cap
- $1.05B
- P/E
- 7.0
Obsidian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.04B
- P/E
- unprofitable
Faeth Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.03B
- P/E
- unprofitable
Avalo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.03B
- P/E
- unprofitable
Arbutus Biopharma Corporation
Healthcare / Biotechnology
- Market Cap
- $1.02B
- P/E
- 6.5
Geron Corporation
Healthcare / Biotechnology
- Market Cap
- $1.01B
- P/E
- unprofitable
Ventyx Biosciences Inc
Healthcare / Biotechnology
- Market Cap
- $1.00B
- P/E
- unprofitable
Lexicon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $996.70M
- P/E
- unprofitable
Immix Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $990.25M
- P/E
- unprofitable
Candel Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $977.91M
- P/E
- unprofitable
Ardelyx, Inc.
Healthcare / Biotechnology
- Market Cap
- $975.95M
- P/E
- unprofitable
SpyGlass Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $967.98M
- P/E
- unprofitable
Adlai Nortye Group Ltd.
Healthcare / Biotechnology
- Market Cap
- $966.61M
- P/E
- unprofitable
Showing 151–200 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.